Toxins Webinar | Fungal Metabolites: From Toxins to Therapeutics, Held on 12 May 2023
On 12 May 2023, MDPI and the journal Toxins (ISSN: 2072-6651) organized a webinar of the Toxins series, titled “Fungal Metabolites: From Toxins to Therapeutics”. The webinar focused on the study of mycotoxins. Mycotoxins are secondary metabolites produced by various filamentous fungi infecting plants and crops. It is now known that mycotoxins, through their biological activities, play crucial roles in fungi biology and ecology. Mycotoxins also have consequences for animal and human health through the ingestion of contaminated food and feeds, with animals/humans in that case being collateral casualties and not primary targets.
Dr. Marc Maresca and Dr. Isabelle Oswald gave an opening introduction first. Then, Prof. Sarah De Saeger introduced the mycotoxin bioanalysis: from human biomonitoring towards exposomics. Dr. Carine Al Ayoubi developed the evaluation of the mutagenicity and metabolism of the emerging mycotoxin versicolorin A, a precursor of aflatoxin B1. Dr. Hamza Olleik talked about whether fungal cyclo-depsipeptides are toxic or therapeutic. Lastly, Dr. Ana Olívia De Souza presented fungi from Brazilian biodiversity as a source of bioactive secondary metabolites.
Please note that this webinar is associated with a Topic in the Toxins journal: “Editorial Board Members’ Collection Series: Fungal Metabolites: From Toxins to Therapeutics”.
You can watch the recorded webinar at the following link: https://youtu.be/6PkHxGxDOds.
Webinar Chair and Keynote Speakers:
- Dr. Marc Maresca, Institut des Sciences Moléculaires de Marseille (ISM2)–BiosCiences–UMR, CNRS Aix Marseille Université, France;
- Dr. Isabelle Oswald, Research Center in Food Toxicology (Toxalim), Toulouse, University of Toulouse, France;
- Prof. Sarah De Saeger, Department of Bioanalysis, Ghent University, Ghent, Belgium;
- Dr. Ana Olívia De Souza, Development and Innovation Laboratory, Instituto Butantan, Sao Paulo, Brazil;
- Dr. Carine Al-Ayoubi, UMR 1331 TOXALIM, INRAE, Toulouse, France;
- Dr. Hamza Olleik, Institut des Sciences Moléculaires de Marseille, Marseille, France.